Cargando…
On the use of wearable sensors as mobility biomarkers in the marketing authorization of new drugs: A regulatory perspective
The loss of mobility is a common trait in multiple health conditions (e.g., Parkinson's disease) and is associated with reduced quality of life. In this context, being able to monitor mobility in the real world, is important. Until recently, the technology was not mature enough for this; but to...
Autores principales: | Viceconti, Marco, Tome, Maria, Dartee, Wilhelmus, Knezevic, Igor, Hernandez Penna, Sabina, Mazzà, Claudia, Caulfield, Brian, Garcia-Aymerich, Judith, Becker, Clemens, Maetzler, Walter, Troosters, Thierry, Sharrack, Basil, Davico, Giorgio, Corriol-Rohou, Solange, Rochester, Lynn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533102/ https://www.ncbi.nlm.nih.gov/pubmed/36213641 http://dx.doi.org/10.3389/fmed.2022.996903 |
Ejemplares similares
-
Toward a Regulatory Qualification of Real-World Mobility Performance Biomarkers in Parkinson’s Patients Using Digital Mobility Outcomes
por: Viceconti, Marco, et al.
Publicado: (2020) -
Mobility endpoints in marketing authorisation of drugs: what gets the European medicines agency moving?
por: Jaeger, Simon U, et al.
Publicado: (2022) -
O.5.2-7 Listening to the patients’ voice: a conceptual framework of the walking experience
por: Delgado-Ortiz, Laura, et al.
Publicado: (2023) -
Acceptability of wearable devices for measuring mobility remotely:
Observations from the Mobilise-D technical validation study
por: Keogh, Alison, et al.
Publicado: (2023) -
Listening to the patients’ voice: a conceptual framework of the walking experience
por: Delgado-Ortiz, Laura, et al.
Publicado: (2023)